HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2910341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Guangzhi Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xijing Hospital, Air Force Medical University of PLA, 710000 Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Phosphofructokinase-2, HMGB1 Protein, Homeodomain Proteins, Glycolysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Instrument Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is an aggressive primary brain tumor. The HOX gene family has been implicated in the pathogenesis of different types of tumors. This research aimed to examine the impact of homeobox D9 (HOXD9) in GBM under hypoxic conditions, as well as to elucidate its underlying molecular mechanisms.
Methods
The study assessed the differential expression of nine HOXD genes in GBM using the Mann-Whitney U test and identified genes with high correlation with the cancer genome atlas (TCGA)-GBM dataset using receiver operating characteristic (ROC) curves. Prognostic genes of GBM patients were identified through a combination of prognostic Kaplan-Meier (KM) curve and Cox analysis. In vitro experiments were conducted using U87-MG and U251-MG cells, and an animal GBM model was constructed. The study also measured the secretion level of high mobility group box 1 (HMGB1) using enzyme-linked immunosorbent assay (ELISA). Glucose uptake and lactate production levels in cells and tissues were analyzed using kits. The expressions of HOXD9 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) were detected by immunofluorescence, and chromatin immunoprecipitation (ChIP) validated their relationship.
Results
HOXD9 was identified as the target gene, showing a significant correlation between HOXD9 expression and prognostic clinical outcomes. Overexpression of HMGB1 enhanced cell proliferation, migration, and the expression levels of HOXD9 and PFKFB3 and promoted HMGB1 secretion, glucose uptake, and lactate generation. HOXD9 bound to the PFKFB3 promoter region in U87-MG and U251-MG cells. Furthermore, PFKFB3 overexpression partially counteracted the suppressive effects of HOXD9 silencing on tumor formation.
Conclusion
HOXD9 promoted hypoxia-induced HMGB1 secretion and glycolysis in GBM through the transcriptional activation of PFKFB3, which in turn promoted tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xijing Hospital, Air Force Medical University of PLA, 710000 Xi'an, Shaanxi, China.
- Department of Medical Administration, The Third People's Hospital of Chengdu, 610014 Chengdu, Sichuan, China.
- Department of Neurosurgery, Xi'an People's Hospital, 710000 Xi'an, Shaanxi, China.
Förderung
- Major Instrument Project of National Natural Science Foundation of China
Zitieren
APA
Xu, G., Sun, J., Wei, L., Yi, X., Han, F., & Liu, W. (2024). HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2910341
Vancouver
Xu G, Sun J, Wei L, Yi X, Han F, Liu W. HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2910341
BibTeX
@article{Xu2024,
author = {Xu, Guangzhi and Sun, Jingchi and Wei, Lizhou and Yi, Xicai and Han, Fuxin and Liu, Weiping},
title = {HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2910341}
}
EUVIMED